Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles
Wei Zhang,1 Yunmei Song,1 Preethi Eldi,1 Xiuli Guo,2 John D Hayball,1,3 Sanjay Garg,1 Hugo Albrecht1 1Centre for Pharmaceutical Innovation and Development, Centre for Drug Discovery and Development, Experimental Therapeutics Laboratory, Sansom Institute for Health Research, School of Pharmacy and M...
Guardado en:
Autores principales: | Zhang W, Song Y, Eldi P, Guo X, Hayball JD, Garg S, Albrecht H |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/92e548053e514f939392d4a7ce8b8d73 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Multifunctional gold nanorods and docetaxel-encapsulated liposomes for combined thermo- and chemotherapy
por: Hua H, et al.
Publicado: (2017) -
Docetaxel-titanate nanotubes enhance radiosensitivity in an androgen-independent prostate cancer model
por: C Mirjolet, et al.
Publicado: (2017) -
Nanoparticles for the treatment of liver fibrosis
por: Poilil Surendran S, et al.
Publicado: (2017) -
An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer
por: Josephina P. M. Vrouwe, et al.
Publicado: (2021) -
Improved Anti-Triple Negative Breast Cancer Effects of Docetaxel by RGD-Modified Lipid-Core Micelles
por: Chen R, et al.
Publicado: (2021)